Side-by-side comparison
Larazotide Acetate vs GHRP-1
Tight-junction regulator developed for celiac disease; reduces intestinal permeability. versus First-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.
Larazotide Acetate
RecoveryTight-junction regulator developed for celiac disease; reduces intestinal permeability.
Top benefits
- ✓Tightens intestinal junctions
- ✓Reduces leaky-gut markers
- ✓Studied in celiac disease
GHRP-1
PerformanceFirst-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.
Top benefits
- ✓Stimulates pituitary GH release
- ✓Synergizes with GHRH analogs
- ✓Lean mass support
| Attribute | Larazotide Acetate | GHRP-1 |
|---|---|---|
| Category | Recovery | Performance |
| Type | linear | linear |
| Chain length | 8 aa | 7 aa |
| Formula | C39H56N10O15 | C46H56N12O6 |
| Common dose | 0.5 mg | 100-300 mcg |
| Frequency | 3x daily, oral | 1-3x daily |
| Top benefit | Tightens intestinal junctions | Stimulates pituitary GH release |
| Top side-effect | Headache | Mild cortisol/prolactin rise |
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.